Advocacy education is an important function of the ABC and its nonprofit organizations. Many members look to the ABC as their key advocacy program, while others have their own large policy shops. Either way, the ABC is committed to staying abreast of brain and health related federal policy issues.
The ABC ensures our membership is adequately prepared to speak with members of Congress and their legislative staff. We have created a Capitol Hill Toolkit to do just this, and provide up-to-date information for our members when conducting meetings and phone calls.
The ABC has created a White Paper that our members can use both as a handout to Members of Congress and to educate themselves about ABC's stance on key policy issues.
Based on our policy issues, the ABC regularly provides statements and letters in support of or opposition of legislative bills.
The ABC relies on our Advocacy Committee, comprised of experts and passionate members dedicated to advancing the ABC’s policy agenda, to help us determine key legislative issues that ABC should be advocating for.
The ABC offers our members an online legislative action center, which allows members to easily contact their Senator or Member of Congress.
The ABC signs on to opportunites sent by like-minded coalitions or other organizations that might be coordinating an effort on a piece of legislation.
The American Brain Coalition has teamed up with the Congressional Neuroscience Caucus in hosting and organizing briefings on Capitol Hill that focus on neuroscience and brain disease.
In an effort to strengthen the support and resources American Brain Coalition (ABC) provides to its membership, ABC seeks to expand its activities into the federal regulatory space. As neuroscience research advances and translational research brings new treatments to market, ABC is uniquely positioned to provide an influential voice to shape federal regulatory policies. By voicing the impact of federal regulatory rules on the neuroscience community, ABC can create an environment that advances its mission and vision by working with agencies like FDA. ABC intends to support its members by providing input to the federal rulemaking process and agency guideline development impacting both neuroscience and translational research that will lead to better treatments, services and support that will improve patients’ quality of life, and cures for individuals with disabling brain disorders. In support of members’ individual FDA regulatory policy efforts, ABC invites members to send opportunities for action so it can be considered by ABC’s Advocacy Committee and information can be distributed to the wider neuroscience community.